Results 231 to 240 of about 867,008 (306)

HIV-1 Vpu interacts with RBM10 to promote HIV-1 infection. [PDF]

open access: yesmSystems
Li B   +13 more
europepmc   +1 more source

Health Preferences and Sorting in the City

open access: yesHealth Economics, EarlyView.
ABSTRACT There are large health inequalities between neighborhoods in many cities of the world. This paper studies individuals' sorting based on health amenities and exposes an important connection between health preferences and the housing market. I estimate a neighborhood choice model using geolocated data from a health survey in New York City and ...
Manuela Puente‐Beccar
wiley   +1 more source

Unintended Consequences of Life‐Saving Pharmaceutical Innovations: How HAART Led to the Resurgence of Syphilis

open access: yesHealth Economics, EarlyView.
ABSTRACT Syphilis, a sexually transmitted infection that can lead to serious health complications, was almost eliminated in the United States by 2000. But since then, its incidence began to increase, recently reaching a 60‐year peak. We suggest that the introduction of the highly active antiretroviral therapy (HAART) drug regimen, which transformed HIV
David Beheshti   +2 more
wiley   +1 more source

An Assessment of Regional Genetic Diversity of HIV-1. [PDF]

open access: yesViruses
Antonova A   +15 more
europepmc   +1 more source

Domestic and International Health Expenditure and Health and Healthcare Use: Evidence From Mozambique

open access: yesHealth Economics, EarlyView.
ABSTRACT Evidence on the relationship between public health expenditure and health is mixed and particularly scarce for low‐income countries. Existing studies overlook the subnational distribution of expenditure and rarely distinguish between sources and governance over funding.
Eliana Chavarría‐Pino   +3 more
wiley   +1 more source

Gastrointestinal MAIT cells in chronic HIV-1 infection. [PDF]

open access: yesJ Immunol
Ferre AL   +8 more
europepmc   +1 more source

Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy. [PDF]

open access: yesNat Immunol
Gieselmann L   +48 more
europepmc   +1 more source

Residual HIV-1 replication

open access: yesBiomedicine & Pharmacotherapy, 2000
openaire   +2 more sources

Home - About - Disclaimer - Privacy